2-FMA: Difference between revisions
>Unity m Grammatics |
>Unity Add stub. |
||
Line 16: | Line 16: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | |||
Although 2-FMA has not been formally studied on the same level as traditional [[amphetamines]], it is thought that it acts as both a [[dopamine]] and [[norepinephrine]] [[releasing agent]]. This means it effectively increases the levels of the norepinephrine and dopamine in the brain by binding to and partially blocking the transporter proteins that normally remove them from the [[synaptic cleft]]. This allows dopamine and norepinephrine to accumulate within the brain, resulting in stimulating and euphoric effects. | Although 2-FMA has not been formally studied on the same level as traditional [[amphetamines]], it is thought that it acts as both a [[dopamine]] and [[norepinephrine]] [[releasing agent]]. This means it effectively increases the levels of the norepinephrine and dopamine in the brain by binding to and partially blocking the transporter proteins that normally remove them from the [[synaptic cleft]]. This allows dopamine and norepinephrine to accumulate within the brain, resulting in stimulating and euphoric effects. | ||